Concepts (294)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Monoterpenes | 10 | 2019 | 46 | 3.82 | Why? |
| Analgesics | 14 | 2018 | 451 | 3.44 | Why? |
| beta-Cyclodextrins | 13 | 2019 | 87 | 3.20 | Why? |
| Oils, Volatile | 8 | 2018 | 127 | 2.09 | Why? |
| Terpenes | 4 | 2018 | 135 | 1.73 | Why? |
| Facial Pain | 5 | 2018 | 43 | 1.36 | Why? |
| Proto-Oncogene Proteins c-fos | 5 | 2018 | 50 | 1.26 | Why? |
| Plant Extracts | 8 | 2019 | 1514 | 1.25 | Why? |
| Hyperalgesia | 5 | 2019 | 61 | 1.20 | Why? |
| Chronic Pain | 6 | 2018 | 736 | 1.08 | Why? |
| Nociception | 4 | 2018 | 25 | 0.96 | Why? |
| Cancer Pain | 2 | 2018 | 91 | 0.84 | Why? |
| Olacaceae | 1 | 2019 | 1 | 0.81 | Why? |
| Antiparasitic Agents | 2 | 2020 | 267 | 0.79 | Why? |
| Leishmania | 1 | 2019 | 28 | 0.77 | Why? |
| Spinal Cord | 5 | 2018 | 281 | 0.74 | Why? |
| Trypanosoma cruzi | 1 | 2019 | 133 | 0.70 | Why? |
| Origanum | 1 | 2016 | 3 | 0.68 | Why? |
| Thymus Plant | 1 | 2016 | 12 | 0.67 | Why? |
| Cymbopogon | 1 | 2016 | 1 | 0.67 | Why? |
| Aldehydes | 1 | 2016 | 56 | 0.63 | Why? |
| Biological Products | 4 | 2018 | 2331 | 0.63 | Why? |
| Arthritis | 1 | 2018 | 288 | 0.55 | Why? |
| Guanidines | 1 | 2018 | 499 | 0.51 | Why? |
| Interleukin-1beta | 1 | 2018 | 992 | 0.48 | Why? |
| Anti-Inflammatory Agents | 4 | 2020 | 6153 | 0.48 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.48 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.47 | Why? |
| Interleukin-10 | 2 | 2018 | 1409 | 0.46 | Why? |
| Neurons | 1 | 2017 | 864 | 0.43 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.43 | Why? |
| Myalgia | 1 | 2016 | 1015 | 0.41 | Why? |
| Pain Management | 1 | 2018 | 854 | 0.40 | Why? |
| Patents as Topic | 4 | 2020 | 224 | 0.39 | Why? |
| Bacteria | 3 | 2019 | 1897 | 0.39 | Why? |
| Cyclohexenes | 2 | 2018 | 9 | 0.37 | Why? |
| Antioxidants | 5 | 2018 | 1593 | 0.37 | Why? |
| Lamiaceae | 2 | 2018 | 29 | 0.36 | Why? |
| Spiro Compounds | 2 | 2017 | 28 | 0.35 | Why? |
| Sesquiterpenes | 2 | 2018 | 77 | 0.34 | Why? |
| Inflammation | 3 | 2019 | 13255 | 0.34 | Why? |
| Animals | 30 | 2020 | 78931 | 0.33 | Why? |
| Cytokines | 2 | 2020 | 15010 | 0.33 | Why? |
| Anti-Bacterial Agents | 6 | 2020 | 10083 | 0.33 | Why? |
| Pain Measurement | 4 | 2017 | 533 | 0.32 | Why? |
| Muscle Strength | 3 | 2018 | 317 | 0.31 | Why? |
| Musculoskeletal Pain | 2 | 2017 | 108 | 0.30 | Why? |
| Hand Strength | 2 | 2016 | 202 | 0.29 | Why? |
| Mice | 13 | 2019 | 21357 | 0.26 | Why? |
| Behavior, Animal | 3 | 2019 | 136 | 0.26 | Why? |
| Disease Models, Animal | 8 | 2019 | 10998 | 0.25 | Why? |
| Drug Carriers | 2 | 2019 | 590 | 0.24 | Why? |
| Drug Repositioning | 2 | 2020 | 5683 | 0.24 | Why? |
| Cyclodextrins | 2 | 2019 | 24 | 0.23 | Why? |
| Steroids | 2 | 2017 | 904 | 0.22 | Why? |
| Plant Stems | 2 | 2018 | 23 | 0.22 | Why? |
| Leprosy, Lepromatous | 1 | 2020 | 22 | 0.22 | Why? |
| Chemistry, Pharmaceutical | 2 | 2019 | 152 | 0.21 | Why? |
| Capsaicin | 2 | 2017 | 19 | 0.21 | Why? |
| Carrageenan | 2 | 2019 | 123 | 0.21 | Why? |
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2019 | 4 | 0.20 | Why? |
| Turnera | 1 | 2019 | 1 | 0.20 | Why? |
| Chromatography, High Pressure Liquid | 3 | 2018 | 669 | 0.20 | Why? |
| Plant Bark | 1 | 2019 | 39 | 0.20 | Why? |
| Parkinson Disease, Secondary | 1 | 2018 | 15 | 0.20 | Why? |
| Sarcoma 180 | 1 | 2018 | 1 | 0.19 | Why? |
| Passiflora | 1 | 2018 | 1 | 0.19 | Why? |
| Population Groups | 1 | 2021 | 212 | 0.19 | Why? |
| Plant Structures | 1 | 2018 | 9 | 0.19 | Why? |
| alpha-Amylases | 1 | 2018 | 10 | 0.19 | Why? |
| Citrus | 1 | 2018 | 29 | 0.18 | Why? |
| Pleurisy | 1 | 2018 | 18 | 0.18 | Why? |
| Health Status Disparities | 3 | 2021 | 4072 | 0.18 | Why? |
| Drug Discovery | 5 | 2020 | 3092 | 0.18 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2018 | 119 | 0.18 | Why? |
| Technology, Pharmaceutical | 1 | 2019 | 82 | 0.18 | Why? |
| Cyclooxygenase 2 | 1 | 2018 | 129 | 0.18 | Why? |
| Oxidative Stress | 3 | 2018 | 2050 | 0.18 | Why? |
| Lippia | 1 | 2017 | 1 | 0.18 | Why? |
| Guanidine | 1 | 2018 | 51 | 0.18 | Why? |
| Plant Oils | 1 | 2018 | 86 | 0.18 | Why? |
| Glycoside Hydrolase Inhibitors | 1 | 2018 | 41 | 0.18 | Why? |
| Heptanol | 1 | 2017 | 1 | 0.18 | Why? |
| Aristolochia | 1 | 2017 | 1 | 0.18 | Why? |
| Hyptis | 1 | 2017 | 1 | 0.18 | Why? |
| Food Analysis | 1 | 2018 | 53 | 0.18 | Why? |
| Tooth Movement Techniques | 1 | 2017 | 19 | 0.18 | Why? |
| Periaqueductal Gray | 1 | 2017 | 2 | 0.18 | Why? |
| Acetic Acid | 1 | 2017 | 50 | 0.18 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 1454 | 0.17 | Why? |
| Nutritive Value | 1 | 2018 | 100 | 0.17 | Why? |
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2017 | 15 | 0.17 | Why? |
| Pain, Procedural | 1 | 2017 | 51 | 0.17 | Why? |
| alpha-Cyclodextrins | 1 | 2017 | 35 | 0.17 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2018 | 159 | 0.17 | Why? |
| Nylons | 1 | 2017 | 34 | 0.17 | Why? |
| Food Handling | 1 | 2018 | 103 | 0.17 | Why? |
| Vitiligo | 1 | 2018 | 76 | 0.17 | Why? |
| Substance P | 1 | 2017 | 23 | 0.17 | Why? |
| Hesperidin | 1 | 2017 | 48 | 0.17 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.17 | Why? |
| Cotton Fiber | 1 | 2017 | 61 | 0.17 | Why? |
| Nanocapsules | 1 | 2017 | 54 | 0.16 | Why? |
| Diazepam | 1 | 2016 | 45 | 0.16 | Why? |
| Pseudomonas aeruginosa | 2 | 2019 | 652 | 0.16 | Why? |
| Cannabinoids | 1 | 2018 | 134 | 0.16 | Why? |
| Brain Chemistry | 1 | 2016 | 49 | 0.16 | Why? |
| Morphine | 1 | 2016 | 71 | 0.16 | Why? |
| Neuralgia | 1 | 2017 | 99 | 0.16 | Why? |
| Brazil | 10 | 2021 | 12582 | 0.16 | Why? |
| Analgesics, Non-Narcotic | 1 | 2017 | 164 | 0.16 | Why? |
| Myocardial Reperfusion Injury | 1 | 2017 | 129 | 0.16 | Why? |
| Phenols | 1 | 2018 | 226 | 0.15 | Why? |
| Motor Activity | 1 | 2018 | 217 | 0.15 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.15 | Why? |
| Fruit | 1 | 2018 | 313 | 0.15 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.15 | Why? |
| Vasodilation | 1 | 2018 | 258 | 0.15 | Why? |
| Alkaloids | 1 | 2018 | 255 | 0.15 | Why? |
| Ibuprofen | 1 | 2017 | 156 | 0.15 | Why? |
| Microbial Sensitivity Tests | 3 | 2019 | 2886 | 0.15 | Why? |
| Biotechnology | 1 | 2018 | 444 | 0.15 | Why? |
| Tandem Mass Spectrometry | 2 | 2018 | 1031 | 0.14 | Why? |
| Cell Movement | 1 | 2019 | 695 | 0.14 | Why? |
| Fibromyalgia | 1 | 2017 | 174 | 0.14 | Why? |
| Drug Design | 2 | 2017 | 2627 | 0.14 | Why? |
| Acetaminophen | 1 | 2017 | 326 | 0.14 | Why? |
| Polyphenols | 1 | 2018 | 283 | 0.14 | Why? |
| Colitis | 1 | 2017 | 266 | 0.14 | Why? |
| Flavonoids | 1 | 2018 | 492 | 0.13 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.13 | Why? |
| Patients | 1 | 2021 | 1167 | 0.12 | Why? |
| Molecular Docking Simulation | 3 | 2018 | 6902 | 0.12 | Why? |
| Interleukins | 1 | 2018 | 762 | 0.12 | Why? |
| Insulin Resistance | 1 | 2018 | 669 | 0.12 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 711 | 0.12 | Why? |
| Solubility | 3 | 2017 | 382 | 0.12 | Why? |
| Rats, Wistar | 3 | 2018 | 621 | 0.11 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| Cell Proliferation | 1 | 2019 | 1973 | 0.11 | Why? |
| Drug Compounding | 3 | 2017 | 386 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.10 | Why? |
| Pain | 1 | 2018 | 1084 | 0.10 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.10 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.10 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.09 | Why? |
| Freeze Drying | 2 | 2019 | 70 | 0.09 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2020 | 8843 | 0.09 | Why? |
| Head and Neck Neoplasms | 1 | 2020 | 1568 | 0.09 | Why? |
| Humans | 30 | 2021 | 930598 | 0.08 | Why? |
| Male | 21 | 2021 | 367725 | 0.08 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.08 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Plant Leaves | 2 | 2018 | 233 | 0.08 | Why? |
| X-Ray Diffraction | 2 | 2017 | 249 | 0.08 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Spectroscopy, Fourier Transform Infrared | 2 | 2017 | 207 | 0.08 | Why? |
| Socioeconomic Factors | 2 | 2020 | 8495 | 0.08 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.07 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.07 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2019 | 3550 | 0.06 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.05 | Why? |
| Preexisting Condition Coverage | 1 | 2021 | 117 | 0.05 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Staphylococcus aureus | 2 | 2017 | 844 | 0.05 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.05 | Why? |
| Brain | 1 | 2017 | 5133 | 0.05 | Why? |
| Reserpine | 1 | 2018 | 3 | 0.05 | Why? |
| Rats | 2 | 2017 | 2764 | 0.05 | Why? |
| Tyrosine 3-Monooxygenase | 1 | 2018 | 32 | 0.05 | Why? |
| Asteraceae | 1 | 2018 | 15 | 0.05 | Why? |
| Streptozocin | 1 | 2018 | 29 | 0.05 | Why? |
| Receptor, Insulin | 1 | 2018 | 18 | 0.05 | Why? |
| Corpus Striatum | 1 | 2018 | 49 | 0.05 | Why? |
| Aminoglycosides | 1 | 2019 | 94 | 0.05 | Why? |
| Lipid Peroxidation | 1 | 2018 | 114 | 0.05 | Why? |
| Rats, Inbred SHR | 1 | 2018 | 58 | 0.05 | Why? |
| alpha-Glucosidases | 1 | 2018 | 39 | 0.05 | Why? |
| Animals, Genetically Modified | 1 | 2018 | 230 | 0.04 | Why? |
| GABA Agents | 1 | 2017 | 9 | 0.04 | Why? |
| Methysergide | 1 | 2017 | 1 | 0.04 | Why? |
| Yohimbine | 1 | 2017 | 1 | 0.04 | Why? |
| Spinal Cord Dorsal Horn | 1 | 2017 | 2 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
| Masks | 1 | 2021 | 8528 | 0.04 | Why? |
| Dietary Fiber | 1 | 2018 | 73 | 0.04 | Why? |
| Glutathione Peroxidase | 1 | 2017 | 83 | 0.04 | Why? |
| Rotarod Performance Test | 1 | 2017 | 7 | 0.04 | Why? |
| Norfloxacin | 1 | 2017 | 13 | 0.04 | Why? |
| Skin Absorption | 1 | 2017 | 18 | 0.04 | Why? |
| Catalase | 1 | 2017 | 97 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Calorimetry, Differential Scanning | 1 | 2017 | 76 | 0.04 | Why? |
| Pain Threshold | 1 | 2017 | 46 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Interleukin-33 | 1 | 2018 | 120 | 0.04 | Why? |
| Gentamicins | 1 | 2017 | 76 | 0.04 | Why? |
| Superoxide Dismutase | 1 | 2017 | 155 | 0.04 | Why? |
| Glucose Tolerance Test | 1 | 2018 | 238 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Islets of Langerhans | 1 | 2018 | 138 | 0.04 | Why? |
| Microscopy, Electron, Scanning | 1 | 2017 | 221 | 0.04 | Why? |
| Interleukin-4 | 1 | 2018 | 367 | 0.04 | Why? |
| Rodentia | 1 | 2018 | 235 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| Interleukin-2 | 1 | 2018 | 443 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Psychomotor Performance | 1 | 2017 | 110 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 382 | 0.04 | Why? |
| Administration, Topical | 1 | 2017 | 272 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Naloxone | 1 | 2017 | 153 | 0.04 | Why? |
| Acetates | 1 | 2017 | 123 | 0.04 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.04 | Why? |
| Information Seeking Behavior | 1 | 2021 | 539 | 0.03 | Why? |
| Amino Acids | 1 | 2018 | 552 | 0.03 | Why? |
| Models, Animal | 1 | 2017 | 788 | 0.03 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Interleukin-17 | 1 | 2018 | 602 | 0.03 | Why? |
| Cell Survival | 1 | 2019 | 1581 | 0.03 | Why? |
| Polymers | 1 | 2017 | 507 | 0.03 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.03 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.03 | Why? |
| Gram-Negative Bacteria | 1 | 2017 | 473 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2019 | 2219 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Liver Function Tests | 1 | 2018 | 1325 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.02 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.02 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.02 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.02 | Why? |
| Poverty | 1 | 2021 | 2302 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2020 | 1757 | 0.02 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Heart | 1 | 2017 | 1791 | 0.02 | Why? |
| Republic of Korea | 1 | 2020 | 5858 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Child | 3 | 2021 | 70012 | 0.02 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2019 | 3347 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Female | 5 | 2021 | 380317 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
Quintans-Júnior's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(294)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_